-
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Nature. 1998 Feb 19;391(6669):795-9
PMID: 9486650
-
A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.
J Exp Med. 1999 Oct 4;190(7):963-72
PMID: 10510086
-
Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
Cancer Res. 1998 Mar 15;58(6):1202-7
PMID: 9515806
-
alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
J Exp Med. 1998 Apr 6;187(7):1047-56
PMID: 9529321
-
Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.
J Exp Med. 1999 Oct 18;190(8):1069-80
PMID: 10523605
-
Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
J Immunol. 1999 Nov 1;163(9):4647-50
PMID: 10528160
-
Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets.
J Immunol. 1998 Apr 15;160(8):3681-8
PMID: 9558068
-
A new look at T cells.
J Exp Med. 1998 May 4;187(9):1367-71
PMID: 9565629
-
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5690-3
PMID: 9576945
-
Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.
Immunity. 1998 Jun;8(6):675-82
PMID: 9655481
-
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
J Immunol. 1998 Oct 1;161(7):3271-81
PMID: 9759842
-
Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis.
Immunity. 1998 Sep;9(3):345-53
PMID: 9768754
-
CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
J Exp Med. 1998 Oct 19;188(8):1521-8
PMID: 9782129
-
CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.
J Exp Med. 1998 Oct 19;188(8):1529-34
PMID: 9782130
-
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].
Immunity. 1998 Oct;9(4):459-66
PMID: 9806632
-
A population of CD62Llow Nk1.1- CD4+ T cells that resembles NK1.1+ CD4+ T cells.
Eur J Immunol. 1998 Oct;28(10):3172-82
PMID: 9808186
-
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
J Exp Med. 1998 Nov 16;188(10):1841-8
PMID: 9815261
-
The Qa-1b molecule binds to a large subpopulation of murine NK cells.
Eur J Immunol. 1998 Dec;28(12):4356-61
PMID: 9862372
-
Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR.
Eur J Immunol. 1998 Dec;28(12):4391-7
PMID: 9862376
-
CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells.
Science. 1999 Jan 8;283(5399):225-9
PMID: 9880256
-
The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis.
J Exp Med. 1999 Feb 1;189(3):483-91
PMID: 9927510
-
Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin.
Eur J Immunol. 1999 Feb;29(2):650-9
PMID: 10064082
-
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.
Science. 1998 Mar 6;279(5356):1541-4
PMID: 9488653
-
Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
J Immunol. 1999 Nov 15;163(10):5338-45
PMID: 10553057
-
NKT cells are phenotypically and functionally diverse.
Eur J Immunol. 1999 Nov;29(11):3768-81
PMID: 10556834
-
Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors.
Eur J Immunol. 2000 Jan;30(1):236-44
PMID: 10602046
-
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers.
Eur J Immunol. 2000 Jan;30(1):300-7
PMID: 10602053
-
NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
J Immunol. 2000 Feb 15;164(4):2009-15
PMID: 10657652
-
alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
Cell Immunol. 2000 Jan 10;199(1):37-42
PMID: 10675273
-
NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.
J Immunol. 2000 Mar 1;164(5):2412-8
PMID: 10679077
-
Murine CD1d-restricted T cell recognition of cellular lipids.
Immunity. 2000 Feb;12(2):211-21
PMID: 10714687
-
The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.
Immunity. 2000 Mar;12(3):241-50
PMID: 10755611
-
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
Eur J Immunol. 2000 Apr;30(4):985-92
PMID: 10760785
-
Production of soluble MHC class II proteins with covalently bound single peptides.
Nature. 1994 May 12;369(6476):151-4
PMID: 8177320
-
Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice.
J Med Chem. 1995 Jun 9;38(12):2176-87
PMID: 7783149
-
Peptide binding and presentation by mouse CD1.
Science. 1995 Jul 14;269(5221):223-6
PMID: 7542403
-
CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.
J Exp Med. 1995 Oct 1;182(4):993-1004
PMID: 7561702
-
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.
J Exp Med. 1995 Oct 1;182(4):1163-8
PMID: 7561690
-
Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice.
Biol Pharm Bull. 1996 Mar;19(3):350-3
PMID: 8924898
-
A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
J Exp Med. 1996 Jul 1;184(1):131-9
PMID: 8691126
-
Phenotypic analysis of antigen-specific T lymphocytes.
Science. 1996 Oct 4;274(5284):94-6
PMID: 8810254
-
KRN7000, a novel immunomodulator, and its antitumor activities.
Oncol Res. 1995;7(10-11):529-34
PMID: 8866665
-
Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells.
J Exp Med. 1996 Oct 1;184(4):1285-93
PMID: 8879200
-
Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse.
Eur J Immunol. 1996 Dec;26(12):2989-98
PMID: 8977295
-
Mouse CD1-specific NK1 T cells: development, specificity, and function.
Annu Rev Immunol. 1997;15:535-62
PMID: 9143699
-
IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.
J Immunol. 1997 Jul 1;159(1):7-10
PMID: 9200431
-
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
Science. 1997 Nov 28;278(5343):1623-6
PMID: 9374462
-
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Science. 1997 Nov 28;278(5343):1626-9
PMID: 9374463
-
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.
Nature. 1998 Jan 8;391(6663):177-81
PMID: 9428763
-
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
J Exp Med. 1999 Apr 5;189(7):1073-81
PMID: 10190898
-
The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
J Exp Med. 1999 Apr 5;189(7):1121-8
PMID: 10190903
-
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
J Exp Med. 1999 Apr 5;189(7):1149-56
PMID: 10190906
-
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
J Immunol. 1999 Jun 1;162(11):6410-9
PMID: 10352254
-
Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
Eur J Immunol. 1999 Jun;29(6):2014-25
PMID: 10382765
-
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.
Immunity. 1999 Jul;11(1):67-77
PMID: 10435580
-
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
J Immunol. 1999 Sep 1;163(5):2373-7
PMID: 10452969
-
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
J Exp Med. 1999 Sep 20;190(6):783-92
PMID: 10499917